Skip to content

A Comparison Between Neurostimulation and Loss of Resistance for Cervical Paravertebral Blocks

A Comparison Between Neurostimulation and Loss of Resistance for Cervical Paravertebral Blocks

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00640380
Enrollment
90
Registered
2008-03-21
Start date
2008-05-31
Completion date
2008-10-31
Last updated
2008-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Surgery

Keywords

cervical, paravertebral, block

Brief summary

Cervical paravertebral blocks (CPVBs) target the brachial plexus from a puncture site situated in the posterior aspect of the neck and represent an alternative to interscalene blocks (ISBs) for shoulder and proximal humeral surgery. Randomized controlled trials comparing CPVB and ISB have found no significant differences in success rate, onset and offset times. Because of the reliability of their cutaneous landmarks, CPVBs have become part of the investigators' standard practice. With this approach, the brachial approach can be identified either with loss of resistance to air (LOR) or nerve stimulation (NS). While some authors have used only LOR and reported good success rates, others have hypothesized that NS may increase the reliability of the block. In the proposed study, for the first time, the 2 methods will be formally compared.

Interventions

CPVB with NS

OTHERLoss of resistance to air

CPVB with LOR

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

are: * age between 18 and 70 years * American Society of Anesthesiologists classification 1-3 * body mass index between 20 and 28

Exclusion criteria

are: * adults who are unable to give their own consent * pre-existing obstructive or restrictive lung disease (assessed by history and physical examination) * pre-existing neuropathy (assessed by history and physical examination) * coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up ie platelets≤ 100, International Normalized Ratio≥ 1.4 or prothrombin time ≥ 50) * renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up ie creatinine≥ 100) * hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up ie transaminases≥ 100) * allergy to local anesthetic agents (LA) * pregnancy * prior cervical spine surgery

Design outcomes

Primary

MeasureTime frame
Success8 months

Secondary

MeasureTime frame
performance time, onset time, side effects8 months

Countries

Canada

Contacts

Primary ContactDe QH Tran, MD, FRCPC
de_tran@hotmail.com(514)934-1934
Backup ContactRoderick J Finlayson, MD, FRCPC
(514)934-1934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026